August 13th 2025
The ADAPT study will evaluate the safety and effectiveness of the Calibreye surgical system in up to 70 patients with refractory glaucoma.
Measuring visual fields with a cloud-based AI platform
May 7th 2021Mohamed Abou Shousha, MD, PhD, and Richard Parrish II, MD, discuss their ARVO 2021 presentation regarding a study analyzing visual field measurements using the Heru Visual Field Multi-platform application downloaded on two different commercially available augmented reality devices.
Watch
Visualizing the optic disc with D-EYE
February 24th 2021Rachel Curtis, MD, a fourth-year resident at Queen's University, Kingston, Ontario, Canada, discusses the highlights from a study comparing a smartphone-compatible device versus traditional direct ophthalmoscopy in teaching medical students how to complete an optic nerve examination.
Watch
Aerie COO: Expanding innovation of glaucoma therapeutics
February 6th 2021Tom Mitro, president, COO of Aerie Pharmaceuticals, discusses the key highlights from an industry panel discussion titled "Innovate without borders," held during the Glaucoma 360 New Horizons Forum, including the company's role in expanding into the global glaucoma therapeutics market.
Watch